Coriell In The News
In a recent publication, the CPMC research study group outlined a more comprehensive genotype-based dosing guide for the drug warfarin(Coumadin®).
Susan Delaney, director of government affairs and health policy at Coriell, was named to a 2016 "Best of Health Care" list.
Collaborating with key opinion leaders, Coriell contributed to a paper outlining perspectives and recommendations for employing genome and exome sequencing in the clinical setting.
Dr. Erin O'Shea, a former chair of the Coriell ICOB, has been named the new president of the Howard Hughes Medical Institute.
Coriell provided insights to The Scientist for a comprehensive feature on human induced pluripotent stem cell automation.
Coriell acknowledges Dr. David Flockhart, a visionary advocate on behalf of precision medicine and a longtime collaborator with the Institute.
Dr. Michael Christman, Coriell's president and CEO, was recently consulted by a prominent national news source for his insights on direct-to-consumer genetic testing.
The 1000 Genomes Project, which houses its sample collection at Coriell Institute, has made inroads for human disease studies with a pair of papers published in Nature.
Dr. Dorit Berlin, Coriell's executive director of biobanking and scientific operations, was invited by the National Institutes of Health to participate in a two-day workshop broadcast to the research community.
Dr. Michael Christman discussed the promise of personalized medicine and its connection to several recent healthcare milestones in an interview with a business journal.
Giving to Coriell
As a non-profit institute, Coriell is fortunate to be engaged in several federally-funded awards. However, we rely on private philanthropy for our more cutting-edge, independent research. Thank you for supporting science!
Meet our Team
Click here to meet our leadership and scientific staff.